This $5 Billion Biotech Home Run Took Less Than a Year : vim

In a deal that now feels like a biotech version of ‘Moneyball,’ Roivant announced it was selling an asset that only 11 months ago it got for free from Pfizer.

Related Keywords

Switzerland , Japan , Swiss , David Risinger , Vivek Ramaswamy , David Wainer , Yaron Werber , Abbvie Humira , Carter Gould , Aamir Malik , Johnson Stelara , Teresa Graham , Telavant Holdings , Teva Pharmaceuticals , Barclays , Drug Administration , Arena Pharmaceuticals , Pfizer , Wall Street Journal , Wall Street , Were Pfizer , Prometheus Biosciences , January Roivant , Leerink Partners , Biotech , Biotechnology , Moneyball , Roivant , Roche , Bowel Disease Treatment , Pharma ,